日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Advancing Treatment in Pediatric Multiple Sclerosis: The Promise of B-Cell-Targeting Therapies

儿童多发性硬化症治疗进展:B细胞靶向疗法的前景

Skarlis, Charalampos; Kotsari, Maria; Anagnostouli, Maria

Neurofilament Biomarkers in Neurology: From Neuroinflammation to Neurodegeneration, Bridging Established and Novel Analytical Advances with Clinical Practice

神经丝生物标志物在神经病学中的应用:从神经炎症到神经退行性疾病,连接已有的和最新的分析进展与临床实践

Daponte, Ariadne; Koros, Christos; Skarlis, Charalampos; Siozios, Daphne; Rentzos, Michail; Papageorgiou, Sokratis G; Anagnostouli, Maria

Type I Interferon-Related Gene Expression and Laboratory Abnormalities in Acute Infection Are Associated with Long COVID Symptom Burden

急性感染期I型干扰素相关基因表达和实验室异常与新冠长期症状负担相关

Emmanouil, Mary; Georgakopoulou, Vasiliki E; Drougkas, Konstantinos; Lembessis, Panagiotis; Skarlis, Charalampos; Gkoufa, Aikaterini; Sipsas, Nikolaos V; Mavragani, Clio P

Monoclonal Antibodies as Therapeutic Agents in Autoimmune and Neurodegenerative Diseases of the Central Nervous System: Current Evidence on Molecular Mechanisms and Future Directions

单克隆抗体作为中枢神经系统自身免疫性疾病和神经退行性疾病的治疗药物:分子机制的最新证据和未来方向

Charalampos Skarlis,Efthalia Angelopoulou,Michail Rentzos,Sokratis G Papageorgiou,Maria Anagnostouli

Type I Interferons in Systemic Autoimmune Rheumatic Diseases: Pathogenesis, Clinical Features and Treatment Options

I型干扰素在系统性自身免疫性风湿病中的作用:发病机制、临床特征和治疗选择

Drougkas, Konstantinos; Skarlis, Charalampos; Mavragani, Clio

Type-I interferon pathway and DNA damage accumulation in peripheral blood of patients with psoriatic arthritis

银屑病关节炎患者外周血中I型干扰素通路和DNA损伤积累

Fragoulis, George E; Ntouros, Panagiotis A; Nezos, Adrianos; Vlachogiannis, Nikolaos I; McInnes, Iain B; Tektonidou, Maria G; Skarlis, Charalampos; Souliotis, Vassilis L; Mavragani, Clio P; Sfikakis, Petros P

First-line disease modifying treatments in pediatric-onset multiple sclerosis in Greece: therapy initiation at more advanced age is the main cause of treatment failure, in a retrospective observational study, with a cohort from a single Multiple Sclerosis Center

希腊一家多发性硬化症中心的回顾性观察研究表明,儿童期发病的多发性硬化症一线疾病修饰治疗失败的主要原因是治疗开始年龄过大。

Skarlis, Charalampos; Markoglou, Nikolaos; Gontika, Maria; Bougea, Anastasia; Katsavos, Serafeim; Artemiadis, Artemios; Chrousos, George; Dalakas, Marinos; Stefanis, Leonidas; Anagnostouli, Maria

The Role of Myositis-Specific and Myositis-Associated Autoantibodies and the Activation of Type I Interferon Pathway in the Generation of Clinical Phenotypes of Inflammatory Myopathies

肌炎特异性和肌炎相关自身抗体以及 I 型干扰素通路的激活在炎症性肌病临床表型产生中的作用

Charalampos Skarlis, Nikolaos Michalakeas, Maria Gerochristou, Sylvia Raftopoulou, Nikolaos Marketos, Kyriaki Boki, Dimitrios Vassilopoulos, Alexandros Panayiotis Stratigos, Dimitrios Boumpas, Clio Mavragani

Differentiating central nervous system demyelinating disorders: The role of clinical, laboratory, imaging characteristics and peripheral blood type I interferon activity

鉴别中枢神经系统脱髓鞘疾病:临床、实验室、影像学特征和外周血I型干扰素活性的作用

Karathanasis, Dimitris K; Rapti, Anna; Nezos, Adrianos; Skarlis, Charalampos; Kilidireas, Constantinos; Mavragani, Clio P; Evangelopoulos, Maria Eleftheria

Distinct type I interferon responses between younger women and older men contribute to the variability of COVID-19 outcomes: Hypothesis generating insights from COVID-19 convalescent individuals

年轻女性和老年男性之间不同的 I 型干扰素反应导致了 COVID-19 结果的差异:从 COVID-19 康复期个体中得出的假设

Clio P Mavragani, Charalampos Skarlis, Ioannis V Kostopoulos, Eirini Maratou, Paraskevi Moutsatsou, Evangelos Terpos, Ourania E Tsitsilonis, Meletios-Athanasios Dimopoulos, Petros P Sfikakis